glp-1 obesity drug news today september 29 2025 Patent and Innovation Trends in and Weight Loss Drugs (2020–2025) GLP-1 Agonists Market Report 2025-2033,

Save on your prescription with low prices from IsraelPharm

While medications that reduce alcohol intake such as naltrexone and acamprosate have central nervous system action, disulfiram reduces alcohol intake through peripheral mechanisms

Perfectly sized for GLP-1 portions

G49, a dual glucagon/glucagon-like peptide-1 receptor agonist, triggers an inter-organ crosstalk between adipose tissue, pancreas and liver, leading to brown fat activation with the final outcomes of increased energy expenditure and body weight loss.

Explore how GLP-1 controls hunger, what the Ozempic effect means, and which foods support natural satiety for better appetite and weight control.

In clinical trials, it led to a weight reduction of up to 16.2%